Ascorbic Acid Inj — Class I drug recall D-0040-2025
Terminated recall by Staska Pharmaceuticals, Inc., reported 2024-11-13, distributed nationwide. Presence of Particulate Matter: Presence of glass particulates.
| Recall number | D-0040-2025 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Staska Pharmaceuticals, Inc., Bennet, NE, United States |
| Recall initiated | 2024-09-30 |
| Classified | 2024-11-07 |
| Reported by FDA | 2024-11-13 |
| Terminated | 2025-08-05 |
| Distributed | Nationwide (US) |
| Quantity | 4,773 vials |
| Reason classes | foreign material, specification failure |
| Lot numbers | SP2400058 |
| Expiration dates | 2024-12-31 |
Product
Ascorbic Acid Inj. Solution, 25,000mg/50mL (500mg/mL), 50mL single use vial, Rx only, Staska Pharmaceuticals, 742 Evergreen Drive, Bennet, NE 68317
Reason for recall
Presence of Particulate Matter: Presence of glass particulates.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0040-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.